Ka-Won Kang

16PUBLICATIONS
43CO-AUTHORS
Medical virologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 24, 2026
Potential of extracellular vesicle-derived microRNAs as a platform for biomarker discovery in acute lymphoblastic leukemia.

|May 29, 2026
Treatment evolution and survival impact of consolidation therapies in mantle cell lymphoma: insights from an Asia-Pacific real-world registry.

|Aug 23, 2024
Use of extracellular vesicle microRNA profiles in patients with acute myeloid leukemia for the identification of novel biomarkers.

Ka-Won Kang, Jeong-An Gim, Sunghoi Hong

|Aug 06, 2024
Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma.

Jun Ho Yi, Seok Jin Kim, Deok-Hwan Yang

|May 16, 2024
Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy.

Kunye Kwak, Yong Park, Byung Soo Kim

|Mar 30, 2024
Combination of acalabrutinib with lenalidomide and rituximab in relapsed/refractory aggressive B-cell non-Hodgkin lymphoma: a single-arm phase II trial.

Changhee Park, Ho Sup Lee, Ka-Won Kang

Pageof 3

Frequent Collaborators

4 joint publications

Byung-Hyun Lee

3 joint publications

Yong Park

3 joint publications

Deok-Hwan Yang

2 joint publications

Dongwon Baek